Sabra Health Care REIT (SBRA) Misses Q2 EPS by 5c, provides guidance

Sabra Health Care REIT (NASDAQ: SBRA) reported Q2 EPS of $0.10, $0.05 worse than the analyst estimate of $0.15. Revenue for the quarter came in at $176.14 million versus the consensus estimate of $166.54 million.

GUIDANCE:

Sabra Health Care REIT sees FY2024 EPS of $0.48-$0.51, versus the consensus of $0.56.
FFO: $1.33 - $1.36
Normalized FFO: $1.36 - $1.39
AFFO: $1.39 - $1.42
Normalized AFFO: $1.41 - $1.44

For earnings history and earnings-related data on Sabra Health Care REIT (SBRA) click here.

You May Also Be Interested In

• FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
• JPMorgan Downgrades Wipro Ltd. (WPRO:IN) (WIT) to Underweight
• JPMorgan Downgrades HCL Technologies (HCLT:IN) to Underweight